Targets miRBase

hsa-miR-200c-3p (MIMAT0000617) (177 targets) in miRTarBase

miRNA gene name experiments
hsa-miR-200c-3p Vldlr
qRT-PCR [1]
In situ hybridization [1]
Immunofluorescence [1]
Western blot [1]
hsa-miR-200c-3p Reln
qRT-PCR [1]
In situ hybridization [1]
Immunofluorescence [1]
Western blot [1]
hsa-miR-200c-3p TUBB3
qRT-PCR [2] [3] [4]
microarray [2]
Western blot [5] [3] [4]
Immunoblot [2]
Immunocytochemistry [2]
Luciferase reporter assay [2] [3]
ELISA [2]
hsa-miR-200c-3p BMI1
Northern blot [6]
qRT-PCR [6] [7] [8]
microarray [8]
Western blot [9] [8] [6]
Immunoblot [7]
Luciferase reporter assay [6] [7] [8] [9]
hsa-miR-200c-3p GEMIN2
Reporter assay [10]
hsa-miR-200c-3p BAP1
microarray [11]
Reporter assay [12]
hsa-miR-200c-3p EP300
microarray [13]
hsa-miR-200c-3p FN1
qRT-PCR [14]
microarray [11]
Western blot [14]
Immunoblot [14]
Luciferase reporter assay [14]
hsa-miR-200c-3p ZFPM2
Reporter assay [12]
Western blot [12]
Luciferase reporter assay [12]
hsa-miR-200c-3p JAG1
qRT-PCR [15]
Immunohistochemistry [15]
hsa-miR-200c-3p PTPN13
qRT-PCR [16]
Reporter assay [16]
Western blot [16]
Luciferase reporter assay [16]
FACS [16]
hsa-miR-200c-3p RNF2
qRT-PCR [8]
microarray [8]
LacZ reporter assay [8]
Western blot [8]
hsa-miR-200c-3p RCOR3
Western blot [17]
Luciferase reporter assay [17]
hsa-miR-200c-3p BRD7
microarray [18]
Western blot [18]
Luciferase reporter assay [18]
Immunohistochemistry [18]
hsa-miR-200c-3p ACVR2B
Western blot [19]
Luciferase reporter assay [19]
hsa-miR-200c-3p MSN
qRT-PCR [14]
Western blot [14]
Immunoblot [14]
Luciferase reporter assay [14]
hsa-miR-200c-3p NTRK2
qRT-PCR [14] [20]
Immunofluorescence [20]
Western blot [14]
Immunoblot [14] [20]
Luciferase reporter assay [14]
hsa-miR-200c-3p ERRFI1
Luciferase reporter assay [21]
hsa-miR-200c-3p CCNE2
Luciferase reporter assay [22]
hsa-miR-200c-3p XIAP
qRT-PCR [23]
Western blot [23]
Luciferase reporter assay [23]
hsa-miR-200c-3p BCL2
qRT-PCR [23]
Western blot [23]
Luciferase reporter assay [23]
hsa-miR-200c-3p TIMP2
Luciferase reporter assay [24]
hsa-miR-200c-3p FBLN5
Western blot [25]
Luciferase reporter assay [24] [25]
hsa-miR-200c-3p VEGFA
Western blot [25]
Luciferase reporter assay [25] [24]
hsa-miR-200c-3p NCAM1
Luciferase reporter assay [26]
hsa-miR-200c-3p IKBKB
Western blot [25]
Luciferase reporter assay [25] [27]
hsa-miR-200c-3p FLT1
qRT-PCR [28]
Western blot [28] [25]
Luciferase reporter assay [28] [25]
hsa-miR-200c-3p KLF9
Western blot [25]
Luciferase reporter assay [25]
hsa-miR-200c-3p TBK1
Western blot [29]
Luciferase reporter assay [29]
PAR-CLIP [30]
hsa-miR-200c-3p PMAIP1
Luciferase reporter assay [31]
PAR-CLIP [32]
hsa-miR-200c-3p NTF3
Luciferase reporter assay [33]
hsa-miR-200c-3p LPAR1
qRT-PCR [34]
Western blot [34]
Luciferase reporter assay [34]
hsa-miR-200c-3p EDNRA
qRT-PCR [34]
Western blot [34]
Luciferase reporter assay [34]
hsa-miR-200c-3p RHOA
qRT-PCR [34]
Western blot [34]
Luciferase reporter assay [34]
hsa-miR-200c-3p KLHL20
Reporter assay [12]
hsa-miR-200c-3p PTPRD
Reporter assay [12]
hsa-miR-200c-3p ELMO2
Reporter assay [12]
hsa-miR-200c-3p ERBIN
Reporter assay [12]
hsa-miR-200c-3p WDR37
Reporter assay [12]
hsa-miR-200c-3p VAC14
Reporter assay [12]
hsa-miR-200c-3p TCF7L1
Reporter assay [12]
hsa-miR-200c-3p RASSF2
Reporter assay [12]
hsa-miR-200c-3p HOXB5
Reporter assay [12]
hsa-miR-200c-3p RIN2
Reporter assay [12]
hsa-miR-200c-3p KLF11
Reporter assay [12]
hsa-miR-200c-3p SEPT7
Reporter assay [12]
hsa-miR-200c-3p SHC1
Reporter assay [12]
hsa-miR-200c-3p ZNF416
CLASH [35]
hsa-miR-200c-3p ILF3
CLASH [35]
hsa-miR-200c-3p MFSD8
CLASH [35]
hsa-miR-200c-3p ATP6
CLASH [35]
hsa-miR-200c-3p FLNA
CLASH [35]
hsa-miR-200c-3p USP22
CLASH [35]
hsa-miR-200c-3p MYB
Western blot [36]
Luciferase reporter assay [36]
hsa-miR-200c-3p ETS1
qRT-PCR [28]
Western blot [28]
Luciferase reporter assay [28]
hsa-miR-200c-3p LRP1B
microarray [37]
hsa-miR-200c-3p WIPF1
microarray [37]
hsa-miR-200c-3p PTPRZ1
microarray [37]
hsa-miR-200c-3p ELAVL2
microarray [37]
hsa-miR-200c-3p DUSP1
microarray [37]
hsa-miR-200c-3p USP25
qRT-PCR [38]
microarray [37]
Immunofluorescence [38]
Western blot [38]
Luciferase reporter assay [38]
Immunohistochemistry [38]
hsa-miR-200c-3p EFNA1
qRT-PCR [39]
Luciferase reporter assay [39]
hsa-miR-200c-3p RND3
qRT-PCR [40]
Western blot [40]
Luciferase reporter assay [40]
hsa-miR-200c-3p DNMT3A
qRT-PCR [41]
In situ hybridization [41]
Western blot [41]
Luciferase reporter assay [41]
hsa-miR-200c-3p DNMT3B
qRT-PCR [41]
In situ hybridization [41]
Western blot [41]
Luciferase reporter assay [41]
hsa-miR-200c-3p SP1
qRT-PCR [41]
In situ hybridization [41]
Western blot [41]
Luciferase reporter assay [41]
hsa-miR-200c-3p CFL2
qRT-PCR [42]
microarray [42]
Luciferase reporter assay [42]
Immunohistochemistry [42]
hsa-miR-200c-3p CDH11
qRT-PCR [42]
microarray [42]
Luciferase reporter assay [42]
Immunohistochemistry [42]
hsa-miR-200c-3p SEC23A
qRT-PCR [42]
microarray [42]
Luciferase reporter assay [42]
Immunohistochemistry [42]
PAR-CLIP [43]
hsa-miR-200c-3p KDR
Western blot [44]
Luciferase reporter assay [44]
hsa-miR-200c-3p HFE
qRT-PCR [45]
Western blot [45]
hsa-miR-200c-3p DLC1
qRT-PCR [45]
Western blot [45]
hsa-miR-200c-3p ATRX
qRT-PCR [45]
Western blot [45]
hsa-miR-200c-3p ZNF217
qRT-PCR [46]
microarray [46]
Western blot [46]
Luciferase reporter assay [46]
hsa-miR-200c-3p RASSF8
PAR-CLIP [47] [48] [43]
hsa-miR-200c-3p UHRF1BP1
PAR-CLIP [32]
hsa-miR-200c-3p ZFHX4
HITS-CLIP [32]
PAR-CLIP [47] [48] [32]
hsa-miR-200c-3p ACSL4
PAR-CLIP [49]
hsa-miR-200c-3p SHCBP1
PAR-CLIP [50]
hsa-miR-200c-3p CAB39
PAR-CLIP [30]
hsa-miR-200c-3p NRBP1
PAR-CLIP [30]
hsa-miR-200c-3p ATP5G3
PAR-CLIP [32]
hsa-miR-200c-3p ZMAT3
PAR-CLIP [30]
hsa-miR-200c-3p N4BP2
PAR-CLIP [49]
hsa-miR-200c-3p QKI
PAR-CLIP [30]
hsa-miR-200c-3p TRPS1
qRT-PCR [51]
hsa-miR-200c-3p ANKRD33B
PAR-CLIP [50] [43] [47] [48] [32]
hsa-miR-200c-3p DNAJB6
PAR-CLIP [50] [30]
hsa-miR-200c-3p DDIT4
PAR-CLIP [47] [48]
hsa-miR-200c-3p KLHL42
PAR-CLIP [47] [48] [32]
hsa-miR-200c-3p NOG
qRT-PCR [51]
hsa-miR-200c-3p PARD6B
PAR-CLIP [50]
hsa-miR-200c-3p DNAJB9
PAR-CLIP [30]
hsa-miR-200c-3p HOXA5
qRT-PCR [51]
hsa-miR-200c-3p SHOC2
PAR-CLIP [48]
hsa-miR-200c-3p NUFIP2
PAR-CLIP [48]
hsa-miR-200c-3p BTC
qRT-PCR [52]
microarray [52]
Western blot [52]
Luciferase reporter assay [52]
Immunoprecipitaion [52]
Immunohistochemistry [52]
ELISA [52]
hsa-miR-200c-3p ZFPM1
qRT-PCR [52]
microarray [52]
Western blot [52]
Luciferase reporter assay [52]
Immunoprecipitaion [52]
Immunohistochemistry [52]
ELISA [52]
hsa-miR-200c-3p PIN1
qRT-PCR [53]
Western blot [53]
Luciferase reporter assay [53]
Flow cytometry [53]
hsa-miR-200c-3p KRAS
qRT-PCR [54]
Western blot [54]
Luciferase reporter assay [54]
PAR-CLIP [30]
hsa-miR-200c-3p NOTCH1
qRT-PCR [55]
Western blot [55]
Luciferase reporter assay [55]
hsa-miR-200c-3p GATA4
qRT-PCR [56]
Immunofluorescence [56]
Western blot [56]
Luciferase reporter assay [56]
Flow cytometry [56]
hsa-miR-200c-3p SUZ12
Luciferase reporter assay [57]
hsa-miR-200c-3p ROCK2
Luciferase reporter assay [57]
hsa-miR-200c-3p UBQLN1
Luciferase reporter assay [58]
Immunohistochemistry [58]
hsa-miR-200c-3p E2F3
Western blot [59]
Luciferase reporter assay [59]
hsa-miR-200c-3p GLI3
qRT-PCR [51]
hsa-miR-200c-3p OSR1
qRT-PCR [51]
hsa-miR-200c-3p PKD1
qRT-PCR [51]
hsa-miR-200c-3p PHF14
PAR-CLIP [49] [60]
hsa-miR-200c-3p CDC14B
PAR-CLIP [49]
hsa-miR-200c-3p ZNF621
PAR-CLIP [49]
hsa-miR-200c-3p CACNG8
PAR-CLIP [49]
hsa-miR-200c-3p FKBP5
PAR-CLIP [43]
hsa-miR-200c-3p M6PR
HITS-CLIP [32]
PAR-CLIP [47] [48] [32] [43]
hsa-miR-200c-3p KIF13A
PAR-CLIP [32] [43] [30]
hsa-miR-200c-3p DENND5B
PAR-CLIP [43]
hsa-miR-200c-3p MALT1
PAR-CLIP [43]
hsa-miR-200c-3p CYP1A1
PAR-CLIP [60]
hsa-miR-200c-3p SERPINH1
PAR-CLIP [30]
hsa-miR-200c-3p TJAP1
PAR-CLIP [30]
hsa-miR-200c-3p TPD52L1
PAR-CLIP [30]
hsa-miR-200c-3p CASP2
PAR-CLIP [30]
hsa-miR-200c-3p AVPR1A
PAR-CLIP [50] [30]
hsa-miR-200c-3p GPX8
PAR-CLIP [30]
hsa-miR-200c-3p ABI2
PAR-CLIP [30]
hsa-miR-200c-3p CLEC2D
HITS-CLIP [32]
PAR-CLIP [47] [48] [30]
hsa-miR-200c-3p UBE2D1
PAR-CLIP [48] [32] [30]
hsa-miR-200c-3p TP53INP1
PAR-CLIP [30]
hsa-miR-200c-3p ELOC
PAR-CLIP [30]
hsa-miR-200c-3p PRRG4
PAR-CLIP [30]
hsa-miR-200c-3p PLCG1
PAR-CLIP [30]
hsa-miR-200c-3p NCOA2
PAR-CLIP [30]
hsa-miR-200c-3p JUN
PAR-CLIP [30]
hsa-miR-200c-3p CELF1
PAR-CLIP [30]
hsa-miR-200c-3p CCNT2
PAR-CLIP [30]
hsa-miR-200c-3p BAG4
PAR-CLIP [30]
hsa-miR-200c-3p TUBB2A
PAR-CLIP [47]
hsa-miR-200c-3p TCF7L2
PAR-CLIP [47] [32]
hsa-miR-200c-3p GPATCH8
PAR-CLIP [47] [48]
hsa-miR-200c-3p LMNB1
PAR-CLIP [47] [50]
hsa-miR-200c-3p C6orf47
PAR-CLIP [50]
hsa-miR-200c-3p TRIM56
PAR-CLIP [50]
hsa-miR-200c-3p MAPK7
PAR-CLIP [50]
hsa-miR-200c-3p CLPB
PAR-CLIP [50]
hsa-miR-200c-3p TXNDC16
PAR-CLIP [50]
hsa-miR-200c-3p UNC119B
PAR-CLIP [50]
hsa-miR-200c-3p TMEM119
PAR-CLIP [50]
hsa-miR-200c-3p TAF1D
PAR-CLIP [50]
hsa-miR-200c-3p PAK2
PAR-CLIP [50]
hsa-miR-200c-3p NLGN4X
PAR-CLIP [50]
hsa-miR-200c-3p ERMP1
PAR-CLIP [50]
hsa-miR-200c-3p PDPK1
PAR-CLIP [48] [32]
hsa-miR-200c-3p CAMSAP2
PAR-CLIP [32]
hsa-miR-200c-3p GATA6
PAR-CLIP [32]
hsa-miR-200c-3p FRS2
PAR-CLIP [32]
hsa-miR-200c-3p CRLF3
PAR-CLIP [48] [32]
hsa-miR-200c-3p CDCA4
PAR-CLIP [32]
hsa-miR-200c-3p YEATS4
PAR-CLIP [48]
hsa-miR-200c-3p MLLT10
PAR-CLIP [48]
hsa-miR-200c-3p CDKN1B
PAR-CLIP [48]
hsa-miR-200c-3p BBX
PAR-CLIP [48]
hsa-miR-200c-3p ARPC3
PAR-CLIP [48]
hsa-miR-200c-3p PSD3
PAR-CLIP [48]
hsa-miR-200c-3p ABT1
PAR-CLIP [48]
hsa-miR-200c-3p PPM1H
HITS-CLIP [61]
hsa-miR-200c-3p INO80D
HITS-CLIP [61]
hsa-miR-200c-3p IGF2
HITS-CLIP [61]
hsa-miR-200c-3p FAM216B
HITS-CLIP [61]
hsa-miR-200c-3p PTPN4
HITS-CLIP [61]
hsa-miR-200c-3p TMEM70
HITS-CLIP [62]
hsa-miR-200c-3p STX16
HITS-CLIP [62]
hsa-miR-200c-3p SEC24A
HITS-CLIP [62]
hsa-miR-200c-3p MTDH
HITS-CLIP [62]
hsa-miR-200c-3p IRS1
HITS-CLIP [63]
hsa-miR-200c-3p NGRN
HITS-CLIP [63]
hsa-miR-200c-3p PABPC1
HITS-CLIP [63]

References

authors journal year Pubmed link title
1 Rebustini et al. Development 2012 22115756 miR-200c regulates FGFR-dependent epithelial proliferation via Vldlr during submandibular gland branching morphogenesis.
2 Cochrane et al. Mol. Cancer Ther. 2009 19435871 MicroRNA-200c mitigates invasiveness and restores sensitivity to microtubule-targeting chemotherapeutic agents.
3 Prislei et al. BMC Cancer 2013 23394580 MiR-200c and HuR in ovarian cancer.
4 Liu et al. Biomaterials 2013 23806972 Targeted delivery of miR-200c/DOC to inhibit cancer stem cells and cancer cells by the gelatinases-stimuli nanoparticles.
5 Cochrane et al. J Oncol 2010 20049172 Loss of miR-200c: A Marker of Aggressiveness and Chemoresistance in Female Reproductive Cancers.
6 et al. None 21207483
7 Lo et al. J. Pathol. 2011 21294122 MicroRNA-200c attenuates tumour growth and metastasis of presumptive head and neck squamous cell carcinoma stem cells.
8 Cao et al. Cancer Cell 2011 21840484 Coordinated regulation of polycomb group complexes through microRNAs in cancer.
9 Shimono et al. Cell 2009 19665978 Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells.
10 Park et al. Genes Dev. 2008 18381893 The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2.
11 Iorio et al. Cancer Res. 2007 17875710 MicroRNA signatures in human ovarian cancer.
12 Hyun et al. Cell 2009 20005803 Conserved MicroRNA miR-8/miR-200 and its target USH/FOG2 control growth by regulating PI3K.
13 Mees et al. Int. J. Cancer 2010 19569050 EP300--a miRNA-regulated metastasis suppressor gene in ductal adenocarcinomas of the pancreas.
14 Howe et al. Breast Cancer Res. 2011 21501518 Targets of miR-200c mediate suppression of cell motility and anoikis resistance.
15 Brabletz et al. EMBO J. 2011 21224848 The ZEB1/miR-200 feedback loop controls Notch signalling in cancer cells.
16 Schickel et al. Mol. Cell 2010 20620960 miR-200c regulates induction of apoptosis through CD95 by targeting FAP-1.
17 Sass et al. BMC Syst Biol 2011 21867514 MicroRNAs coordinately regulate protein complexes.
18 Park et al. Gynecol. Oncol. 2012 22015043 The interactions between MicroRNA-200c and BRD7 in endometrial carcinoma.
19 Senanayake et al. Carcinogenesis 2012 22431721 miR-192, miR-194, miR-215, miR-200c and miR-141 are downregulated and their common target ACVR2B is strongly expressed in renal childhood neoplasms.
20 Kopp et al. PLoS ONE 2012 23209748 miR-200c sensitizes breast cancer cells to doxorubicin treatment by decreasing TrkB and Bmi1 expression.
21 Adam et al. Clin. Cancer Res. 2009 19671845 miR-200 expression regulates epithelial-to-mesenchymal transition in bladder cancer cells and reverses resistance to epidermal growth factor receptor therapy.
22 Cai et al. Graefes Arch. Clin. Exp. Ophthalmol. 2012 22183793 MicroRNA-200 is commonly repressed in conjunctival MALT lymphoma, and targets cyclin E2.
23 Zhu et al. Cancer Chemother. Pharmacol. 2012 21993663 miR-200bc/429 cluster modulates multidrug resistance of human cancer cell lines by targeting BCL2 and XIAP.
24 Chuang et al. Endocr. Relat. Cancer 2012 22685266 miR-200c is aberrantly expressed in leiomyomas in an ethnic-dependent manner and targets ZEBs, VEGFA, TIMP2, and FBLN5.
25 Panda et al. Reprod Sci 2012 22569286 Endometrial miR-200c is altered during transformation into cancerous states and targets the expression of ZEBs, VEGFA, FLT1, IKKβ, KLF9, and FBLN5.
26 Oishi et al. Hepatology 2012 22707408 Transcriptomic profiling reveals hepatic stem-like gene signatures and interplay of miR-200c and epithelial-mesenchymal transition in intrahepatic cholangiocarcinoma.
27 Chuang et al. PLoS ONE 2014 24755559 miR-200c regulates IL8 expression by targeting IKBKB: a potential mediator of inflammation in leiomyoma pathogenesis.
28 Hur et al. Gut 2013 22735571 MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasis.
29 Lin et al. J. Cell. Biochem. 2013 22991189 miR-200c enhances radiosensitivity of human breast cancer cells.
30 Farazi et al. Genome Biol. 2014 24398324 Identification of distinct miRNA target regulation between breast cancer molecular subtypes using AGO2-PAR-CLIP and patient datasets.
31 Lerner et al. PLoS ONE 2012 22615771 MiR-200c regulates Noxa expression and sensitivity to proteasomal inhibitors.
32 Kishore et al. Nat. Methods 2011 21572407 A quantitative analysis of CLIP methods for identifying binding sites of RNA-binding proteins.
33 Howe et al. PLoS ONE 2012 23185507 miR-200c targets a NF-κB up-regulated TrkB/NTF3 autocrine signaling loop to enhance anoikis sensitivity in triple negative breast cancer.
34 Luna et al. PLoS ONE 2012 23272142 Regulation of trabecular meshwork cell contraction and intraocular pressure by miR-200c.
35 Helwak et al. Cell 2013 23622248 Mapping the human miRNA interactome by CLASH reveals frequent noncanonical binding.
36 Cesi et al. Cell Cycle 2011 22101269 TGFβ-induced c-Myb affects the expression of EMT-associated genes and promotes invasion of ER+ breast cancer cells.
37 Huh et al. Br. J. Cancer 2013 23807165 Dysregulation of miR-106a and miR-591 confers paclitaxel resistance to ovarian cancer.
38 Li et al. Mol. Cancer 2014 24997798 miRNA-200c inhibits invasion and metastasis of human non-small cell lung cancer by directly targeting ubiquitin specific peptidase 25.
39 Li et al. Mol. Carcinog. 2014 23065816 G-A variant in miR-200c binding site of EFNA1 alters susceptibility to gastric cancer.
40 Chang et al. Pathol. Oncol. Res. 2014 23821457 MicroRNA-200c regulates the sensitivity of chemotherapy of gastric cancer SGC7901/DDP cells by directly targeting RhoE.
41 Tang et al. Clin. Cancer Res. 2013 23995857 miR-200b and miR-200c as prognostic factors and mediators of gastric cancer cell progression.
42 Luo et al. J Transl Med 2013 23497265 A systematic evaluation of miRNA:mRNA interactions involved in the migration and invasion of breast cancer cells.
43 Whisnant et al. MBio 2013 23592263 In-depth analysis of the interaction of HIV-1 with cellular microRNA biogenesis and effector mechanisms.
44 Shi et al. PLoS ONE 2013 24205206 MiR-200c increases the radiosensitivity of non-small-cell lung cancer cell line A549 by targeting VEGF-VEGFR2 pathway.
45 Pacurari et al. Int. J. Oncol. 2013 23708087 The microRNA-200 family targets multiple non-small cell lung cancer prognostic markers in H1299 cells and BEAS-2B cells.
46 Bai et al. Int. J. Cancer 2014 24615544 MiR-200c suppresses TGF-β signaling and counteracts trastuzumab resistance and metastasis by targeting ZNF217 and ZEB1 in breast cancer.
47 Memczak et al. Nature 2013 23446348 Circular RNAs are a large class of animal RNAs with regulatory potency.
48 Hafner et al. Cell 2010 20371350 Transcriptome-wide identification of RNA-binding protein and microRNA target sites by PAR-CLIP.
49 Gottwein et al. Cell Host Microbe 2011 22100165 Viral microRNA targetome of KSHV-infected primary effusion lymphoma cell lines.
50 Lipchina et al. Genes Dev. 2011 22012620 Genome-wide identification of microRNA targets in human ES cells reveals a role for miR-302 in modulating BMP response.
51 Li et al. Int. J. Pediatr. Otorhinolaryngol. 2013 23294929 MicroRNA expression profiling and target genes study in congenital microtia.
52 Yang et al. J. Clin. Invest. 2014 24762440 ZEB1 sensitizes lung adenocarcinoma to metastasis suppression by PI3K antagonism.
53 Luo et al. Cancer Res. 2014 24786790 Prolyl isomerase Pin1 acts downstream of miR200c to promote cancer stem-like cell traits in breast cancer.
54 Kopp et al. Oncotarget 2014 24368337 The proto-oncogene KRAS is targeted by miR-200c.
55 Cama et al. Acta Neuropathol. 2013 23955600 Integrative genetic, epigenetic and pathological analysis of paraganglioma reveals complex dysregulation of NOTCH signaling.
56 Huang et al. Stem Cell Res 2014 24365599 miR-200c and GATA binding protein 4 regulate human embryonic stem cell renewal and differentiation.
57 Peng et al. Br. J. Cancer 2013 24169343 Direct targeting of SUZ12/ROCK2 by miR-200b/c inhibits cholangiocarcinoma tumourigenesis and metastasis.
58 Sun et al. Int. J. Cancer 2015 25044403 MiR-200c inhibits autophagy and enhances radiosensitivity in breast cancer cells by targeting UBQLN1.
59 Tao et al. Biochim. Biophys. Acta 2014 25017995 Autoregulatory feedback loop of EZH2/miR-200c/E2F3 as a driving force for prostate cancer development.
60 Skalsky et al. PLoS Pathog. 2012 22291592 The viral and cellular microRNA targetome in lymphoblastoid cell lines.
61 Karginov et al. Genes Dev. 2013 23824327 Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates.
62 Xue et al. Cell 2013 23313552 Direct conversion of fibroblasts to neurons by reprogramming PTB-regulated microRNA circuits.
63 Chi et al. Nature 2009 19536157 Argonaute HITS-CLIP decodes microRNA-mRNA interaction maps.